HHS seems poised to exert control over USPSTF Ransohoff: The task force is the pinnacle of evidence-based medicine

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Do multi-cancer detection tests provide a net benefit? NCI aims to answer this question, beginning with the Vanguard feasibility trial which recently started accruing patients.

July 30, 2025

Vol.51 No.29

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.

July 25, 2025

Vol.51 No.29

By Claire Marie Porter

Cancer Policy

NIH says it’s moving away from animal-based models

NIH has announced that it will no longer be issuing Notices of Funding Opportunities exclusively supporting animal models.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

Cancer Policy

CMS proposes policy to move away from hospital-based care

The Centers for Medicare & Medicaid Services issued a proposed rule that would update Medicare payment policies and rates for hospital outpatient departments and ambulatory surgical centers, or ASCs, for calendar year 2026.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

Cancer Policy

HHS asks employees to report instances of “DEI policies that caused discrimination”

The U.S. Department of Health and Human Services is searching for examples of employees, grant recipients, and contractors harmed by DEI efforts of the federal government in the last five years, as part of the Trump administration’s mission to end initiatives set up to diversify the workforce and bolster opportunities forhistorically disadvantaged groups.

Publications based on NIH-funded science must be made free immediately, HHS decrees

Researchers funded by NIH will now be required to make their scientific papers available to read for free as soon as they are published in a peer-reviewed journal.

July 03, 2025

Vol.51 No.26

By Claire Marie Porter

HHS seems poised to exert control over USPSTF

Ransohoff: The task force is the pinnacle of evidence-based medicine

YOU MAY BE INTERESTED IN

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

NIH says it’s moving away from animal-based models

CMS proposes policy to move away from hospital-based care

HHS asks employees to report instances of “DEI policies that caused discrimination”

Publications based on NIH-funded science must be made free immediately, HHS decrees

Renew today!

Subscriber content

Never miss an issue!

Login

HHS seems poised to exert control over USPSTF

Ransohoff: The task force is the pinnacle of evidence-based medicine

YOU MAY BE INTERESTED IN

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER directorHis appointment came out of “proximity” to Makary and Bhattacharya

NIH says it’s moving away from animal-based models

CMS proposes policy to move away from hospital-based care

HHS asks employees to report instances of “DEI policies that caused discrimination”

Publications based on NIH-funded science must be made free immediately, HHS decrees

Never miss an issue!

Login

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya